BWM
WST icon

BNC Wealth Management’s West Pharmaceutical WST Stock Holding History

BNC Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-542
Closed -$223K – 131
2022
Q1 		$223K Buy
542
+85
+19% +$33.3K 0.11% 110
2021
Q4 		$214K Buy
+457
New +$197K 0.1% 114
2020
Q4 		– Sell
-387
Closed -$106K – 471
2020
Q3 		$106K Buy
+387
New +$102K 0.07% 110

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BNC Wealth Management's WST Position: Q2 2022 in Review

BNC Wealth Management sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 542 shares — an estimated $223K sold.

BNC Wealth Management first reported a position in WST in Q3 2020 and held it in 3 quarters. The position peaked at $223K in Q1 2022. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • BNC Wealth Management reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • BNC Wealth Management sold 542 West Pharmaceutical shares in Q2 2022, an estimated $223K.
  • BNC Wealth Management first reported a position in West Pharmaceutical in Q3 2020 and held it in 3 quarters.
  • BNC Wealth Management's West Pharmaceutical position peaked at $223K in Q1 2022.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on BNC Wealth Management's 13F filing for Q2 2022, filed 25 Jul 2022.